Skip to main navigation Skip to search Skip to main content

A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Subjects with Moderate or Severe Systemic Lupus Erythematosus (SLE)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/9/19 → 05/8/22

Funding

  • Idorsia Pharmaceuticals Ltd.: $61,474.60